TITLE

Big pharma and good corporate citizenship

AUTHOR(S)
Cassels, Alan
PUB. DATE
August 2008
SOURCE
CMAJ: Canadian Medical Association Journal;8/26/2008, Vol. 179 Issue 5, p411
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the Netherland-based Access to Medicine Foundation's minted social responsibility index, which will track and measure the attempts of individual drug companies in ensuring that access to efficiency and affordable medicine is part of their corporate business plan. Launched in June 2008, the index was formed by the Access to Medicine Foundation in the Netherlands. The Foundation aims to raise consciousness of the relevant issue of global access to medicine by ranking 20 of the world's largest drug companies by how well they perform around 28 key indicators grouped into 8 main criterion.
ACCESSION #
33923045

 

Related Articles

  • Survival in shifting markets depends on adaptability. Mitchell, Bradley; Sherman, Sallie // Drug Store News;5/1/2006, Vol. 28 Issue 6, p20 

    The article urges the drug stores industry in the United States to be prepared for the upcoming shifts which have occurred and are occurring in other industries. There are changes occurring in the various components of the network of relationships that affect drug stores. There will also be...

  • Payment and other legal obstacles slow telemedicine growth. Jones, John W. // Managed Healthcare Executive;Mar2004, Vol. 14 Issue 3, p53 

    Reports on the impact of payment and other legal obstacles on telemedicine growth. Success of telemedicine in the provider community and among consumers; Benefits of telemedicine; Issuance of the first official accredition in the telehealth field by the Joint Commission on Accredition of...

  • Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. Lexchin, Joel // Science & Engineering Ethics;Jun2012, Vol. 18 Issue 2, p247 

    Pharmaceutical companies fund the bulk of clinical research that is carried out on medications. Poor outcomes from these studies can have negative effects on sales of medicines. Previous research has shown that company funded research is much more likely to yield positive outcomes than research...

  • Good Medicine: Rebuilding Trust in the Health Care System.  // Public Relations Strategist;Summer2005, Vol. 11 Issue 3, p44 

    This article focuses on the Health Academy's conference in Washington, D.C., held in May 2004. In the past year. the pharmaceutical industry has lost a great deal of respect in the eyes of the average American consumer. The crisis in confidence is really a crisis that got driven by deep fears...

  • Deals.  // BioPharm International;May2006, Vol. 19 Issue 5, p16 

    The article offers pharmaceutical news briefs. QSV Biologics, Ltd. deals with Tissue Therapies, Ltd. in developing and manufacturing clinical quantities of specific therapeutic protein components to accelerate healing of burns. Laureate Pharma creates an agreement with Bradmer Pharmaceuticals to...

  • Impatience over patients. CHASE, JAMES // Medical Marketing & Media;Nov2013, Vol. 48 Issue 11, p8 

    The author discusses the catalysts for organizational change in contemporary pharmaceutical, the evolution of digital and patient centricity. He states that there are strong parallels between the two paradigms as digital fluency and patient centricity both have been a long time coming in pharma....

  • Steve Anderson, President and CEO. Anderson, Steve // Chain Drug Review;1/4/2016, Vol. 38 Issue 1, p123 

    The author offers his perspectives on the outlook of the pharmacy industry for 2016. Topics discussed include the National Association of Chain Drug Stores' (NACD) open letter for presidential candidates calling for reliance on pharmacists and advocacy for pro-patient and pro-pharmacy public...

  • Partnering Up To Beat The Squeeze. JED GRAHAM // Investors Business Daily;1/20/2015, pA08 

    One of the most powerful middleman industries in the global economy is emerging from more than a half-decade of difficult transition.

  • Strengthening its core to compete.  // Drug Store News;4/1/2008, Vol. 30 Issue 4A, p27 

    The article reports that Longs Drugs Stores Corp. is strengthening its businesses and building a stronger foundation for the tough competition in the retail drug industry in the U.S. The company has made significant progress by remaining competitive and profitable business despite strong...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics